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Waldbronn, Germany), equipped with temperature control 
and diod array detection (DAD). Separation was performed 
using an untreated fused silica capillary of 64.5 cm × 50 µm 
i.d with an effective length of 56 cm to the detector window 
obtained from Polymicro Technologies (Phoenix, AZ, 
USA). Sample injection was performed electrokinetically 
for 3 kV per 3 s. The detection wavelength used was 200 
nm and the capillary temperature was maintained at 25oC. 
Data were collected and processed on computer using 
ChemStation software (Agilent Technologies). At the 
beginning of each day, the capillary was flush for  5 
minutes with 1.0 N NaOH, followed by 2 minutes deionized 
water, then 3 minutes with 0.1 N NaOH, 2 minutes with 
deionized water and finally 10 minutes with running buffer. 
All sample injection was performed in triplicate. 
 
 
3. RESULTS & DISCUSSION 
 
3.1    Effect of HP-γ-CD concentrations 
 
Effect of different HP-γ-CD concentrations was first 
explored to resolve the two enantiomers of enilconazole. 
The HP-γ-CD was varied in order to obtain the best 
separation of enilconazole using CD-MEKC. The HP-γ-CD 
concentration was varied in the concentration range 20 -   
50 mM with 50 mM SDS in 20 mM phosphate buffer 
solution at pH 8.0, the applied voltage 25 kV and 25oC. The 
typical result for the separation of enilconazole enantiomers 
using CD-MEKC with different HP-γ-CD concentrations is 
shown in Fig 1. It can be seen that there was no chiral 
resolution for enilconazole at 20 mM HP-γ-CD. While at 30 
mM HP-γ-CD, enilconazole enantiomers were only partially 
separated. Enantiomeric separation of enilconazole was 
successfully achieved when 40 mM HP-γ-CD was 
employed. The resolution decreased when 50 mM HP-γ-CD 
was used in the separation solution. 
The migration time of enilconazole enantiomers were 
gradually shortened with increasing HP-γ-CD 
concentration. High concentration of HP-γ-CD increased 
the probability of analyte to include in its cavity. More 
enilconazole enantiomers will become incorporated in the 
HP-γ-CD phase as compared to the micelles phase. Since 
the HP-γ-CD moved at faster speed, thus the enantiomers 
will be transported quickly towards the detector and made 
the analysis time shortened.  
The chiral recognition arise when the analyte make 
some interaction with HP-γ-CD. This interaction caused 
two labile diastable formed. The different in stability of the 
two diastereomers cause the mobility of the two 
enantiomers are differing. The two enantiomers will migrate 
at different velocity and will be detected by the detector at 
individual migration time. Thus, two peaks can be observed 
from the electropherogram. The best enantioresolution of 
enilconazole was obtained at 40 mM HP-γ-CD. At this 
concentration the best resolution (Rs= 1.2) with analysis 
time within 9 min was obtained. Based on this data, 
optimum concentration of HP-γ-CD was set at 40 mM.  
3.2    Effect of SDS concentrations 
 
The effect of SDS concentration was then investigated, 
ranging from 30 to 50 mM. The typical result for the 
separation of enilconazole enantiomers using CD-MEKC 
with different SDS concentrations is shown in Fig 2. It was 
found that as the concentration of SDS was increased, the 
migration time also increased.  
The increased in SDS concentration caused an 
increased in analysis time due to the increasing viscosity of 
the solution. Analyte will take a longer time to travel 
towards the detector because of higher viscosity. SDS is 
anionic micelles and supposes to move toward the positive 
electrode. However, due to the higher EOF as compared to 
the electrophoretic flows in the buffer solution, SDS was 
force to move towards negative electrode with retarded 
velocity. Thus, SDS will move slower than the buck 
solution. The higher concentration of SDS required longer 
time for EOF to attract analyte that accompanying with the 
SDS towards the detector window. 
The resolution was increased with increasing SDS 
concentration. The effect of SDS concentration on 
enantioresolution of enilconazole can be explain by the 
retention factor, k. The higher the k value, the higher 
resolution can be obtained. In MEKC, the k value can be 
manipulating by adjusting the concentration of micelles and 
was given by the following equation [9]:  
 
k ≈ Kv(Csrf – CMC) 
 
The above equation suggests that the capacity factor, k is 
linearly dependent on the surfactant concentration. The 
relationship between SDS concentration and resolution 
described above was explained about the single peak appear 
in the electropherogram obtained. At concentration 30 mM, 
there was no enantioresolution observed at all. This 
observation probably due to the small concentration of SDS 
used and the concentration was not significant enough to 
separate the enilconazole enantiomers. The best 
enantioresolution of enilconazole enantiomers was obtained 
when   40 mM SDS was employed. At this concentration 
the best resolution (Rs = 1.3) with a short analysis time 
within 9 min was obtained. Based on this data, optimum 
concentration of SDS was set at 40 mM. 
 
3.3    Analytical performance of the CD-MEKC  
 
Performance of the optimized CD-MEKC was 
examined in terms of linearity, repeatability and LOD. The 
calibration curves were linear for the two stereoisomers of 
enilconazole (r2 > 0.980). Good repeatabilities in migration 
time, peak area and peak height were obtained in terms of 
RSD%. The LOD obtained was 44 – 45 µg mL-1. The 
linearity, repeatability and LOD of the optimized CD-
MEKC method are summarized in Table 1.    
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Figure 1: Enantioseparation of enilconazole using CD-MEKC with different HP-γ-CD concentration. separation solution: 20-50 mM HP-
γ-CD, 50 mM SDS in 20 mM phosphate buffer (pH 8); capillary, 64.5 cm × 50 µm I.D. (effective length, 56 cm); applied voltage, 25 kV; 
temperature, 25 oC; sample injection, 3 kV for 3 s; sample, 200 µg mL-1 (in methanol). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Enantioseparation of enilconazole using CD-MEKC with different SDS concentration. separation solution: 30 -  50 mM SDS, 
40 mM HP-γ-CD in 20 mM phosphate buffer (pH 8); other conditions as in Fig 1. 
 
 
  Hermawan et.al / Journal of Fundamental Sciences Vol. 7, No. 1 (2011) 78-81. 
| 81 | 
 
Table 1: Linearity, repeatability and LOD (S/N = 3) for enilconazole enantiomers in the optimized CD-MEKC 
 
Parameters             Peak 1 Peak 2 
Concentration range                 50-200 µg/mL    50-200 µg/mL 
1Regression equation                y = 0.590x-3.41    y = 0.609x-4.435 
r2          0.981                                                     0.983 
RSD %( n = 3) 
Migration time                            0.27                                                     0.08 
Peak area                                    0.07                                                      2.1 
Peak height                                 2.8                                                        6.1 
LOD(µg/mL)                               44                                                        45 
 
                        1 linearity range: 50 – 200 µg mL-1 ; y = peak area, x = concentration (µg mL-1) 
 
 
  
4. CONCLUSION  
 
In the present work, the optimization of HP-γ-CD 
concentration and SDS concentration were successfully 
developed for separation of enilconazole enantiomers. The 
mixture of 40 mM HP-γ-CD, 40 mM SDS, in 20 mM 
phosphate buffer solution at pH 8.0, applied voltage 25 kV 
and temperature 25oC was able to separate the enilconazole 
enantiomers. The migration time was within 9 minutes and 
resolution obtained was 1.30. Good repeatabilities were 
obtained in term of RSD% (n = 3) for migration time, peak 
area and peak height ranging from 0.07 to 6.1%. However, 
the LOD obtained is quite high, (44-45 µg/mL). MEKC 
method usually suffers from low concentration sensitivity 
due to only small sample volume introduced and limited 
optical pathlenght for on-capillary photometric detection. 
Thus, some approach need to be employed together with 
MEKC to increase the concentration sensitivity. On-line 
preconcentration technique is seemed to be a good approach 
to recover the sensitivity problem suffers by MEKC 
technique. The present works can be used as the preliminary  
study for the on-line preconcentration and chiral 
separation of enilconazole. 
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